Podcasts about nutromics

Joining Jack McCullough in this thought-provoking episode is Rowan Wilkie, CFO at Nutromics. He looks back on the origin story of their company, which has a high chance of making a huge difference in continuous diagnostic monitoring. Rowan reflects on how he found himself working Nutromics, the most valuable lessons he learned from his mentors, and how he became a mentor to other promising business leaders. He also shares their fundraising and financial strategies, as well as his insights on how generative AI could change the entire market right now.To book a demo with Payhawk, click here. To book a demo with Planful, click here.

About the Guest(s):Peter Vranes is the co-founder and CEO of Nutromics. With over 25 years of entrepreneurial experience, Peter previously took a skincare company from startup to a successful trade sale. Fascinated by health diagnostics, he shifted his focus to medtech. Alongside co-founder Hitesh Mehta, Peter is on a mission to revolutionize health diagnostics and patient outcomes through continuous biosensing technology. Under his leadership, Nutromics has raised $55 million and assembled a team of 60 experts in Melbourne and San Diego.Episode Summary:In this episode of Shape the System, host Vincent Turner speaks with Peter Vranes, co-founder of Nutromics, about revolutionizing health diagnostics to improve patient outcomes. Peter shares his journey from the skincare industry to pioneering technology in medtech. The discussion introduces Nutromics' innovative approach to continuous health monitoring through biosensors, aimed at transforming reactive healthcare into a proactive model.The conversation delves into the current state of patient diagnostics, emphasizing its inefficiencies and limitations. Peter illustrates how critical diagnostic markers often fluctuate quickly, making timely and continuous data crucial for effective treatment decisions. He explains how Nutromics' platform leverages DNA-based biosensors to provide real-time monitoring, thus addressing life-threatening conditions like heart attacks and sepsis with unprecedented accuracy and speed. The discussion also touches on the company's collaboration with top-tier universities and its future plans to extend the technology's reach from hospitals to everyday individual health monitoring.Key Takeaways:Legacy Diagnostic Systems: Today's healthcare heavily relies on blood draws that provide single data points, often delayed, for over 70% of clinical decisions, which can lead to inefficiencies and life-threatening oversights.Continuous Monitoring: Nutromics is developing a platform of DNA-based sensors to provide continuous, real-time health data, crucial for conditions with rapidly changing biomarkers like heart attacks and drug dosages for sepsis.Target Vertical Integration: Nutromics strategically focuses on high-impact verticals (ICU, cardiology, renal, etc.) to establish strong use cases and optimize their technology's application before a broader rollout.Proactive Healthcare Vision: The ultimate goal is shifting from reactive to proactive healthcare by creating a system that alerts individuals of health issues before they become symptomatic.Collaborative Innovation: Peter underscores the importance of collaborating with world-class researchers and being persistent in securing and developing groundbreaking technologies.Notable Quotes:"70% of all clinical decisions are based on lab diagnostics like the ones we described; the current system has been a legacy system for decades.""The holy grail of healthcare is shifting from a reactive to a proactive model, rendering symptomatic diagnosis obsolete.""We are on our way to revolutionizing diagnostics, which is what we're trying to do.""When you know you've got a tech that can save someone's life and people are dying today because this isn't in the market, you have to go.""We feel privileged to be given the opportunity to do this. That's what drives us, that legacy we are going to leave behind."Resources:Nutromics Website: NutromicsUniversity of California, Santa Barbara: UCSBTim Ferriss' Books: The Four-Hour Body, The Four-Hour WorkweekDive deep into the future of health diagnostics with Peter Vranes and learn how Nutromics is changing the system. Don't miss this insightful episode and stay tuned for more transformative stories from Shape the System. Shape the System is  an independent podcast with support from KPMG High Growth Ventures More about KPMG High Growth VenturesScale up for success. We're here for that.We navigate founders and their teams to the services they need to reach their next milestone. From startup to scale and beyond. No matter where you are right now, we'll get you the help you need to drive your business forward. We help founders fully realise their potential, as well as the potential of their team and their business, by connecting them to the expertise, skills and resources they need at every stage of their growth journey.Our extensive experience in partnering with evolving businesses means that we can provide you with tailored support as well as independent and practical insights. Whether you are looking to refine your strategy, establish your operations, prepare for a capital raise, expand abroad or simply comply with regulatory requirements, we are here to help.Links:Website: About (highgrowthventures.com.au)LinkedIn: https://www.linkedin.com/showcase/kpmg-enterprise-high-growth-ventures/Contacts: highgrowthventures@kpmg.com.au 

At the HLTH 2023 conference in Las Vegas, ANDHealth led the Australian Delegation of healthtech companies keen to showcase their solutions to the US market. During the event Pete visited all of the Australian company delegate attendees to learn more about the problem they are solving to bring you this episode today. Guests include Bronwyn Le Grice - CEO of ANDHealth, Peter Cranes - CEO & Co Founder of Nutromics, Scott Taylor - CEO & Co Founder of Perx Health, Nishanth Krishnananthan - CO-CEO of Vantari VR, John Kelly - CEO & Founder of Atomo Diagnostics, and Francis White - Vice President of Global Business Development at Adherium. The conversation delves into the complexity of the Australian and US healthcare systems, challenges faced by health tech companies, and the importance of understanding these systems for successful market entry and collaboration.Key Takeaways:1. The significance of personal connections and learning from companies with US market experience.2. The importance of targeting the right people, having a focused strategy for meetings, and understanding the unique challenges in the US healthcare market.3. The value of building relationships, understanding the US audience, and addressing the needs of patients, healthcare providers, and employers in the US market.4. Emphasis on the potential for business in the US due to its size, but the need to navigate the complexity of the market.Timestamps:[01:16] Bronwyn Le Grice - CEO, ANDHealth[04:32] Helen Souris - CEO, Cardihab[06:10] Peter Vranes - CEO & Co Founder, Nutromics[09:20] Nishanth Krishnananthan - CO-CEO, Vantari VR[11:58] John Kelly - CEO & Founder, Atomo Diagnostics[13:53] Jill Freyne - Deputy Chief Scientist, CSIRO[15:58] Edwina Wenkart - CEO, PenCS & Kean Seng Lim - Chief Medical Advisor, PenCS[18:46] Francis White - Vice President of Global Business Development, Adherium[22:18] Scott Taylor - CEO & Co Founder - Perx Health[24:00] Shayne Mele - CEO, Scripted Health Technology[26:33] Alex Naoumidis & Chris Naoumidis - Co Founder & Co CEO, Mindset HealthCheck out the episode and full show notes on the Talking HealthTech website.Loving the show? Leave us a review, and share it with someone who might get some value from it.Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content. For more information visit talkinghealthtech.com/thtplus

This episode's Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, we spend time with Dr. Agim Beshiri, Chief Medical Officer of Nutromics, an international leader pioneering continuous diagnostic monitoring to transform personalized care. Bringing over 20 years of clinical and industry expertise, Agim is driven to advance patient-centric precision medicine. While together, Agim shares how Nutromics utilizes synthetic DNA sensors for real-time, first-order molecular recognition. Additionally, Agim unpacks the future of scaling personalized treatment through continuous multiplexed monitoring. We also discuss reinventing antiquated blood testing methodologies and paradigm shifts enabling preventative intervention. Join us as Agim outlines a vision for mimicking implanted diagnostic tools across diverse disease states and to gain inspiration from his dedication to elevating global standards of care through innovative diagnostics. Let's go! Episode Highlights:Agim brings deep medical affairs experience to transform diagnostic testingHow Nutromics uses synthetic DNA sensors for continuous, multiplexed monitoringWays in which Nutromics enables real-time precision dosing adjustments and early interventionsAgim envisions scaling continuous diagnostics across diverse disease statesHow Agim exemplifies commitment to profoundly advancing personalized medicine About our Guest: Agim Beshiri, M.D., is the Chief Medical Officer (CMO) at MedTech startup Nutromics. His passion is in elevating the standard of care for all patients. With over 20 years' experience in the IVD field both in the clinical setting and industry. Dr Beshiri developed methods and collaborations that enabled patient-centric application of diagnostics addressing underserved patients in disease states from cardiology to oncology.A leading industry expert in developing a medical affairs organization and driving medical research and education. With a broad background in internal medicine, hematology, general cardiology, and laboratory medicine, Dr Beshiri initiated and collaborated on research programs resulting in over 800 research collaborations and over 1000 publications.Prior to Nutromics, Dr Beshiri was Senior Medical Director at Abbott Laboratories where he developed supporting their Diagnostics organization for over 16 years. His clinical experience includes the Brooke Army Medical Center in Texas, the 452nd Combat Support Hospital in Wisconsin and Aurora/Advocate Clinical Laboratories in Wisconsin and Illinois, and South-eastern Europe.Dr. Beshiri is a member of several organizations, including the American Medical Association, American Heart Association, European Society of Cardiology, International Society for Laboratory Hematology, European Hematology Association, American Society of Hematology, and American Society of Clinical Oncology. He has also served on guideline subcommittees for the Clinical and Laboratory Standards Institute.Links Supporting This Episode:Nutromics Website: CLICK HEREDr. Agim Beshiri LinkedIn page: CLICK HERENutromics Twitter page: CLICK HERE Mike Biselli LinkedIn page:

Host Mike Moore interviews Co-Founder & CEO of Nutromics, Peter Vranes. Nutromics is developing the world's first continuous, real-time, wearable diagnostic monitoring device that utilizes multiple DNA-based sensors with microneedles. It has been described as a “Lab-On-A-Patch”, where the number of diagnostics it can monitor is limited solely by the number of microneedles it can fit on the patch. Resources & Links Mike Moore https://www.linkedin.com/in/michaeljeffreymoore/ https://www.linkedin.com/company/thebleedingedgeofdigitalhealth/

Clinicians today are hampered by insufficient and delayed lab diagnostics. Nutromics has created a breakthrough technology that combines multiple DNA sensors with microneedles. The diagnostic platform does everything a blood test does and more: it is a lab-on-a-patch. On this episode of Here's an Idea™, Peter Vranes, CEO and Co-Founder of Nutromics, discusses how the patch will track multiple, crucial targets continuously and in real-time, giving clinicians critical, personalized insights.

Pitching POV–Startup Medtech Message with Peter Vranes! This week, your Message Engineer Podcast host, Maureen Shaffer (CEO of Mingletoe LLC), sits down with Peter Vranes to discuss pitching to venture capital (VC), when marketing must begin at a medtech startup, and why messaging is both challenging and critically important.Listen/Watch NOW to hear key takeaways, including: Why relationships are far more important than pitch decksWhy 100 pitches are the goal in startup fundraisingWhy marketing must start Day OneThe power of one clear message across the customer continuum, and much more!Peter has more than 20 years of C-level experience and is currently CEO + Co-Founder at Nutromics. Nutromics is developing a “lab on a patch” to provide continuous diagnostic monitoring of drugs, proteins, and metabolites, with the vision of “a patch for every patient.” Their initial target is vancomycin to prevent adverse events, such as acute kidney injury, outside the narrow therapeutic window. At Nutromics, he and his COO and Co-Founder, Hitesh Mehta, have raised $20 million to date, including $14 million in Fall 2022. Prior to Nutromics, he was chief executive officer and founder of multiple startups in the cosmeceutical space, including Biocore whose product was distributed at 2,500 retail outlets before the company was successfully sold. LISTEN to the full episode on the Message Engineer Podcast everywhere! Including Apple Podcast, Audible,Spotify, Amazon Music (try “Alexa, play Message Engineer podcast”), and iHeartRadio.WATCH full video episode: https://www.youtube.com/@messageengineerFOLLOW Peter Vranes: https://www.linkedin.com/in/peter-vranes-085bb810/FOLLOW Maureen Shaffer: https://www.linkedin.com/in/maureenashaffer/______________________________

Dr. Agim Beshiri is the Chief Medical Officer at Nutromics, where they have developed technology for continuous diagnostic monitoring through a ‘lab-on-a-patch' approach. Dr. Beshiri is a leading industry expert in developing medical affairs organizations and driving medical research and education. Prior to joining Nutromics, he contributed at Abbott Laboratories for over 16 years, serving as Senior Medical Director. In this episode he shares about earning a medical degree and applying it inside industry, what doctors and companies need to recognize about each other, what Medical Affairs is and how it is structured, the long-term objectives of a company and how medical affairs can drive massive growth, and how Nutromics is positioned to help change how monitoring of critical parameters is performed.Links from this episode:Agim Beshiri, MD LinkedInNutromicsMastering Medical Device:WebsitePat Kothe LinkedIn

Hear from Peter Vranes & Hitesh Mehta, co-founders of Nutromics about how they are building the future of health monitoring to prevent chronic disease (and deaths) and welcome to episode 4 of this curiosity sseries taking you inside topics, companies and industries. Please enjoy exploring your curiosity as I did mine through this conversation!***KEY POINTS COVERED03:50 - What is Nutromics and the problem they're solving? 05:20 - How did they turn their idea into reality? 07:00 - Creating an impact with medical devices 11:00 - How does the operation in the ecosystem work? 13:20 - Example of therapeutic drug monitoring with vancomycin 14:45 - Does Nutromics save the system money by managing outpatients vs inpatients? 17:03 - How is the dosing of Vancomycin cost effective through technology? 20:35 - Potential size of the opportunity and market 26:30 - Biggest threat to their technology 28:30 - Biggest surprise to date 30:50 - Smart watches and wearable devices***Find out more about Curiosity Center at www.curiositycenter.xyz Find out more about Nutromics at https://www.nutromics.com.au/Share your feedback or questions directly with us at vidit@curiositycenter.xyz or via Linkedin / Instagram

In this episode, Giovanni Lauricella and Peter Vranes discuss his background as an entrepreneur, how they founded Nutromics, what the company is doing, where does Australia fit in the global MedTech industry, the advantageous clinical trial environment in Australia, their experience raising capital and closing their most recent round, the lack of investors and how that affects startups in Australia, their experience with Medtech Innovator, why Peter always takes investor meetings, and so much more. Peter Vranes LinkedIn Nutromics Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

In this episode, Giovanni Lauricella and Peter Vranes discuss his background as an entrepreneur, how they founded Nutromics, what the company is doing, where does Australia fit in the global MedTech industry, the advantageous clinical trial environment in Australia, their experience raising capital and closing their most recent round, the lack of investors and how that affects startups in Australia, their experience with Medtech Innovator, why Peter always takes investor meetings, and so much more. Peter Vranes LinkedIn Nutromics Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

Today's guest is our very first international guest on the Medical Management Podcast!  All the way from Australia, Peter Vranes came over to share his pieces of advice on being a Chief Executive Officer. Peter reckons how entrepreneurship and uncertainty have taught him to be a better person, and he loves challenging himself. Imposter syndrome, authenticity, technology, and the future of medicine are some of the main topics in this conversation. Peter wants to help people through technology in the healthcare industry, so tune in to learn more about his journey! Don't worry, we will have Peter on our next episode too because he has more things to share. 

In this episode of Medsider Radio, we caught up with chemical engineer and serial entrepreneur Peter Vranes, the Co-Founder and CEO of Nutromics, an Australian medtech company that is developing a digitally connected wearable patch to track molecular targets.Previously, Peter founded Biocore Technologies, which developed natural cosmeceutical skincare brands with distribution in 1,500 retailers throughout Australia. He had a successful exit in 2013.In this fun discussion, Peter explains how he learned to embrace publicity as a necessary part of doing business, why getting your device approved goes beyond government regulatory bodies, and the reason he never stops raising money. Before we jump into the conversation, I wanted to mention a few things:If you're into learning from proven medtech and healthtech leaders, and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You'll get access to gated articles, and lots of other interesting healthcare content. Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced healthcare leaders about the nuts and bolts of running a business and bringing products to market. This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.In addition to the entire back catalog of Medsider interviews over the past decade, Premium members get exclusive Ask Me Anything interviews and masterclasses with some of the world's most successful medtech founders and executives. Since making the premium memberships available, I've been pleasantly surprised at how many people have signed up. If you're interested, go to medsider.com/subscribe to learn more.Lastly, here's the link to the full interview with Peter if you'd rather read it instead.

How to Raise Money for your Idea ($10million worth), with Hitesh Mehta How do you raise money for an idea - that isn't event yet made into a product. That takes talent, an idea that ignites interest and some major selling skills, and so in this interview Hitesh Mehta, the co-Founder of Nutromics. is on his way to create a life saving. He has managed to raise ten million BEFORE the product has even been developed and he has only been in business since 2017, that's a major victory that you can sell a high stakes product before its even created and enrol others in your vision. If you've ever needed to know how to raise money for your idea and enrol others into your vision, whilst still being a newbie entrepreneur, this is a MUST to listen. Listen IN. --- Send in a voice message: https://anchor.fm/rita-joyan/message

In this Outcomes Rocket MedTech podcast, we are excited to feature Peter Vranes, CEO & Co-Founder of Nutromics, an Australian medtech company revolutionizing healthcare through continuous real-time molecular monitoring. Peter discusses how Nutromic's smart patch biosensor solves some of the healthcare challenges in chronic disease prevention and management, acute diseases, and therapeutic drug monitoring. He shares the lightbulb moment which led to the creation of Nutromic, dives into vancomycin, what happens when patients have overdosed, and how the smart patch can help clinicians have accurate, real-time data, continuous monitoring of vancomycin. He also talks about therapeutic drug monitoring for a whole range of drugs, the benefits for both physicians and patients, and the different pivots the company did that led to the smart patch. Peter also shares his insights on being transparent and building relationships of trust with VCs. The company is preparing for a clinical trial in a few months and has closed a 7.5 multimillion-dollar grant. Click this link to the show notes, transcript, and resources: outcomesrocket.health

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics. Earlier this summer, Rafael sat down with Peter Vranes and Hitesh Mehta, co-founders of Nutromics. Nutromics is developing a next generation lab-on-skin, a wearable device for continuous monitoring of health-critical biomarkers. Let's get right to it. Visit https://www.genialis.com/2021/08/23/real-time-multiplexed-biomarkers-the-next-generation-of-continuous-monitoring-with-peter-vranes-and-hitesh-mehta--podcast-25/ for highlights and links from this episode.

Hitesh is Co-Founder and Co-CEO at Nutromics and is passionate about bring innovative new wearable and AI-driven health-tech products and solutions to the market for impact. Hitesh has more than 10+ years of experience consulting globally within Healthcare and previously worked at IBM Watson Health.

Today's episode features a Reimagining Healthcare livestream panel covering the topic of: “The promise of biosensing: Achieving the vision of personalised medicine”. On this panel, we discuss the commercial and real-world opportunities coming about from the convergence of these fields to address some of the world's biggest healthcare challenges and problems that will move toward achieving the vision of personalised medicine. This livestream has come together via a collaboration between coreplus, Nutromics and HealthTechX.   The live panel features the following experts: Yianni Serpanos — Founder and Executive Director of HealthTechX, Founder and CEO of coreplus and Host of the Reimagining Healthcare podcast and livestream. Professor Justin Gooding — Scientia Professor at UNSW; Founding Co-director, New South Wales Smart Sensing Network; and Founding Co-director, The Australian Centre for NanoMedicine and one of the world's leading experts on biosensing. Dr Simon Corrie — Senior Lecturer at Monash University and Chief Investigator, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland and an expert in biosensors and bioassays. Professor Kevin Plaxco — Professor of Chemistry and Biochemistry at the University of California, Santa Barbara (UCSB); Vice-chair of Chemistry and biochemistry at UCSB; Associate Director of Centre for Bioengineering at UCSB, Inventor of Nutromics' biosensing technology and a world leader in the field of biosensing. Dr Kaylyn Leung — Postdoctoral Researcher at the University of California, Santa Barbara's Department of Chemistry and Biochemistry. Kaylyn is a researcher who is developing and optimising electrochemical-aptamer biosensors.   Connect: https://www.linkedin.com/in/yianni-serpanos/ https://www.linkedin.com/company/healthtechx https://www.instagram.com/my_healthtechx/ https://www.meetup.com/HealthTechX/ See omnystudio.com/listener for privacy information.

Today's guest is Rob Crowder, Head of Product at Nutromics in Australia, which has a booming life science community. Nutromics is a medical device company with a hardware and software component that includes a wearable micro-needle biosensor and software companion. Nutromics's vision is a world with zero preventable deaths due to a lack of timely biological data, and it's mission is to revolutionize health care through real-time molecular monitoring. Maybe one day, everybody will be wearing biosensors and have real time data from a molecular-level information superhighway.Rob is a former GM of a Medtech product development company and has worked with more than 100 companies on feasibility, design, and commercialization of novel products. Key Takeaways:How to approach the challenges of developing hardware and software productsHow to have the right mindset as a product leaderHow to balance quality and product development velocityShow Notes: NutromicsApplication to be on the show: From Lab to LaunchQualioMusic by keldez

Rob Crowder is the Head of Product at Nutromics, a high-growth medical sensor device company. Rob has over 20 years in the product development field. He has worked for General Electric, PWC, and more. Today Rob is going to share some valuable knowledge on how inventors, startups, and small manufacturers can learn from the best practices on user journey mapping for medical devices - How to apply these MedTech best practices to your next product, whether it’s a medical device or any other physical product invention. EPISODE LINKS Rob Crowder / Nutromics Links: Personal LinkedIn: https://www.linkedin.com/in/robcrowder/ Company Website: https://www.nutromics.com.au/ The Product Startup Podcast Links: Website: https://www.ProductStartup.com/ Instagram: https://www.instagram.com/ProductStartup/ LinkedIn: https://www.linkedin.com/company/ProductStartup/ Facebook Page: https://www.facebook.com/ProductStartup/ Facebook Group: https://www.facebook.com/groups/ProductStartup/ Pinterest: https://www.pinterest.com/ProductStartup/ Twitter: https://twitter.com/ProductStartup YouTube: https://www.youtube.com/MakoInvent   Mako Design Links: Website: https://www.makodesign.com/ YouTube: https://www.youtube.com/MakoInvent Instagram: https://www.instagram.com/MakoInvent/ LinkedIn: https://www.linkedin.com/company/MakoDesign/ Facebook: https://www.facebook.com/MakoInvent/ Pinterest: https://www.pinterest.com/MakoInvent/ Twitter: https://twitter.com/MakoInvent/   Kevin Mako Links: Instagram: https://www.instagram.com/Entrepreneurs/ LinkedIn: https://www.linkedin.com/in/KevMako/ Quora: https://www.quora.com/profile/Kevin-Mako Facebook: https://www.facebook.com/KevMakoPage/ Twitter: https://twitter.com/KevMako/   Thanks for tuning in! See you next time.

Peter Vranes is a Co-founder of Nutromics, an Australian med-tech company providing continuous, real-time molecular monitoring using a smart patch biosensor platform. In this episode, Peter shares his story from having already built and exited a successful cosmeceutical brand and how that led to meeting his co-founder to build Nutromics. He also talks about how that experience led to them participating in a med-tech accelerator, and their journey through capital raising and proof of concepts.   Key takeaways: Conventional molecular tests and monitoring leaves big gaps in terms of the information needed to support decision making (especially where monitoring of fast-moving molecular targets is needed). Nutromics has developed a one patch platform that can be adapted to many applications and can ensure, continuously and in real-time, that a patient is receiving a dose at the right time and level to stay within the therapeutic range. The molecular sensing technology has a microneedle array platform and an aptamer sensor platform that promises flexibility for this Smart Patch to be used in many different therapeutic contexts.   Resources and links: https://www.linkedin.com/in/peter-vranes-085bb810/ https://www.nutromics.com.au/   Connect: Listen to other episodes of Reimagining Healthcare Connect with Yianni Serpanos on LinkedIn Follow HealthTechX on LinkedIn Follow HealthTechX on Instagram Follow HealthTechX on Meetup See omnystudio.com/listener for privacy information.

Hitesh Mehta is the co-founder of Nutromics an Australian med-tech start-up. The Nutromics Biosensor Platform is solving some of the biggest healthcare challenges we face today. Their wearable sensor and software solutions will reimagine how we prevent chronic disease and manage acute conditions. The Nutromics vision is a world with zero preventable deaths due to a lack of timely biological patient data. In this episode Hitesh outlines how exactly Nutromics will do this and more: 6:36 - Hitesh details his background and the founding story of Nutromics 8:13 - Molecular targeting and how Nutromics will use it to revolutionize healthcare 10:56 - The technology behind their CMM wearable device 13:04 - What important health data can be learned from monitoring patients' interstitial fluid 14:45 - The Lab on Skin approach to measuring electrochemical signatures 16:15 - Electrochemical signaling and developing sensor technology to read these signals 20:00 - How to join Nutromics and global recruitment 23:21 - Transition from a sick-care to a healthcare system Reach out to Hitesh here Learn more about Nutromics at their website: http://www.nutromics.com.au/ Stay up to date with medtalkcracy on socials! Instagram, LinkedIn, Twitter Co-Founders: Zion Maynard Alia Myers

In this episode, Hitesh, Peter and I discuss Nutromics, the problem they see in healthcare, lessons learned so far, and advice for medtech start-up companies. Peter Vranes bio: Peter Vranes is a Chemical Engineer and serial entrepreneur. Peter is the co-founder of Nutromics, an Australian MedTech company revolutionising healthcare through continuous real time molecular monitoring. The company's innovative Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring. Prior to Nutromics, Peter founded Biocore Technologies and lead the team with the development and commercialisation of several natural cosmeceutical skincare brands that were distributed in 1,500 retailers throughout Australia. The company was successfully sold in 2013. Hitesh Mehta bio: Hitesh is Co-Founder and Co-CEO at Nutromics (Nutromics.com.au) and passionate about bring innovative new wearable and AI driven health-tech products and solutions to the market for impact. Hitesh has more than 10+ years of experience consulting globally within Healthcare and previously worked at IBM Watson Health.

Will smart patch biosensors solve our biggest health challenges?  Peter Vranes is the co-founder of Nutromics, an Australian MedTech company revolutionising healthcare through continuous real time molecular monitoring.  They have created an innovative Smart Patch biosensor platform that aims to solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring. In this episode, Peter takes a deep dive into their technology and the fascinating world of enzymatic sensors and aptamers. Peter also shares some of his own insights as a self proclaimed serial entrepreneur, and shares some useful advice for anyone wanting to start up their own business. Check out the episode and full show notes here. To see the latest information, news, events and jobs on offer at Nutromics, visit their Talking HealthTech Directory here.